ADHD is associated with impulsivity, hyperactivity, and trouble with focus, but kids with ADHD may also struggle with motor ...
Review of Klarity for ADHD Klarity provides online ADD/ADHD diagnosis and treatment in a growing number of states through its team of certified and licensed medical providers. They’ve provided a more ...
FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.
Morning Overview on MSNOpinion

5 ADHD myths people still stubbornly believe

Attention-deficit/hyperactivity disorder is one of the most researched neurodevelopmental conditions, yet 5 ADHD myths people ...
The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...
The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor designed to address the core symptoms of ADHD in children and adults.
Health Secretary Wes Streeting has launched an independent review into the prevalence, trends, and clinical management of mental health conditions, attention deficit hyperactivity disorder (ADHD), and ...
By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 20, 2026 (HealthDay News) — Taking acetaminophen during pregnancy does not ...
Too much executive functioning is expected from ADHD-ers, ignoring key struggles of the disability. Colleges and universities ...
There is no link between acetaminophen use in pregnancy and autism or ADHD risk for the offspring, a new gold-standard review ...
Understanding ADHD isn't just about accommodation, Lauren Krasnow writes—it's about accessing exceptional talent that your ...